Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln
12/04/2024 15:19
April 12 (Reuters) - Aslan Pharmaceuticals Ltd
7A90y.BE :
* ASLAN PHARMACEUTICALS: TO OFFER AND SELL ADSS HAVING AN
OFFERING
PRICE OF UP TO $12 MILLION FROM TIME TO TIME
Source text for Eikon: ID:n0000950170-24-043871
Further company coverage: 7A90y.BE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln